Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial

Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Abhishake Lahiri, Debaleena Bhowmik, Janani Srinivasa Vasudevan, Ranjeet Maurya, Akshay Kanakan, Sachin Sharma, Manish Kumar, Praveen Singh, Rammohan Roy, Kausik Chaudhury, Rajsekhar Maiti, Saugata Bagchi, Ayan Maiti, Md. Masoom Perwez, Abhinandan Mondal, Avinash Tewari, Samik Mandal, Arpan Roy, Moumita Saha, Durba Biswas, Chikam Maiti, Sayantan Chakraborty, Biswanath Sharma Sarkar, Anima Haldar, Bibhuti Saha, Shantanu Sengupta, Rajesh Pandey, Shilpak Chatterjee, Prasun Bhattacharya, Sandip Paul, Dipyaman Ganguly
doi: https://doi.org/10.1101/2020.11.25.20237883
Yogiraj Ray
1Infectious Disease & Beleghata General Hospital, Kolkata, India
2Department of Tropical Medicine, School of Tropical Medicine, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Dipyaman@iicb.res.in jaggs.nbmc@gmail.com
Shekhar Ranjan Paul
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Purbita Bandopadhyay
3IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ranit D’Rozario
3IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jafar Sarif
3IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhishake Lahiri
4Division of Structural Biology & Bioinformatics, CSIR-Indian Institute of Chemical Biology, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debaleena Bhowmik
4Division of Structural Biology & Bioinformatics, CSIR-Indian Institute of Chemical Biology, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janani Srinivasa Vasudevan
5CSIR-Institute of Genomics and Integrative Biology, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ranjeet Maurya
5CSIR-Institute of Genomics and Integrative Biology, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akshay Kanakan
5CSIR-Institute of Genomics and Integrative Biology, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sachin Sharma
5CSIR-Institute of Genomics and Integrative Biology, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manish Kumar
5CSIR-Institute of Genomics and Integrative Biology, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Praveen Singh
5CSIR-Institute of Genomics and Integrative Biology, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rammohan Roy
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kausik Chaudhury
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajsekhar Maiti
1Infectious Disease & Beleghata General Hospital, Kolkata, India
6Department of Pediatrics, Sagar Dutta Hospital & College of Medicine, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saugata Bagchi
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayan Maiti
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Md. Masoom Perwez
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhinandan Mondal
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avinash Tewari
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samik Mandal
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arpan Roy
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moumita Saha
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Durba Biswas
7Department of Immunohematology & Blood Transfusion, Medical College Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chikam Maiti
7Department of Immunohematology & Blood Transfusion, Medical College Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sayantan Chakraborty
8Department of Critical Care Medicine, Tata Medical Center, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Biswanath Sharma Sarkar
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anima Haldar
1Infectious Disease & Beleghata General Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bibhuti Saha
2Department of Tropical Medicine, School of Tropical Medicine, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shantanu Sengupta
5CSIR-Institute of Genomics and Integrative Biology, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajesh Pandey
5CSIR-Institute of Genomics and Integrative Biology, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shilpak Chatterjee
3IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prasun Bhattacharya
7Department of Immunohematology & Blood Transfusion, Medical College Hospital, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandip Paul
4Division of Structural Biology & Bioinformatics, CSIR-Indian Institute of Chemical Biology, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dipyaman Ganguly
3IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Dipyaman@iicb.res.in jaggs.nbmc@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction A single center open label phase II randomised control trial was done to assess the pathogen and host-intrinsic factors influencing clinical and immunological benefits of passive immunization using convalescent plasma therapy (CPT), in addition to standard of care (SOC) therapy in severe COVID-19 patients, as compared to patients only on SOC therapy.

Methods Convalescent plasma was collected from patients recovered from COVID-19 following a screening protocol which also included measuring plasma anti SARS-CoV2 spike IgG content. Retrospectively, neutralizing antibody content was measured and proteome was characterized by LC-MS/MS for all convalescent plasma units that were transfused to patients. Severe COVID-19 patients with evidence for acute respiratory distress syndrome (ARDS) with PaO2/FiO2 ratio 100-300 (moderate ARDS) were recruited and randomised into two parallel arms of SOC and CPT, N=40 in each arm. Peripheral blood samples were collected on the day of enrolment (T1) followed by day3/4 (T2) and day 7 (T3). RT-PCR and sequencing was done for SARS-CoV2 RNA isolated from nasopharyngeal swabs collected at T1. A panel of cytokines and neutralizing antibody content were measured in plasma at all three timepoints. Patients were followed up for 30 days post-admission to assess the primary outcomes of all cause mortality and immunological correlates for clinical benefits.

Results While across all age-groups no statistically significant clinical benefit was registered for patients in the CPT arm, significant immediate mitigation of hypoxia, reduction in hospital stay as well as survival benefit was recorded in severe COVID-19 patients with ARDS aged less than 67 years receiving convalescent plasma therapy. In addition to its neutralizing antibody content a prominent effect of convalescent plasma on attenuation of systemic cytokine levels possibly contributed to its benefits.

Conclusion Precise targeting of severe COVID-19 patients is necessary for reaping the clinical benefits of convalescent plasma therapy.

Clinical trial registration Clinical Trial Registry of India No. CTRI/2020/05/025209

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Clinical Trial Registry of India No. CTRI/2020/05/025209

Funding Statement

D.G. acknowledges funding for the RCT and associated immune monitoring studies from Council of Scientitific Industrial Research (CSIR), Govt. of India (MLP-129); R.P. acknowledge funding from CSIR (MLP-2005) and Fondation Botnar.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The randomized control trial (RCT) on passive immunization with convalescent plasma therapy and all associated studies were done with informed consent from the patients according to the recommendations and ethical approval from the Institutional Review Boards of all the concerned institutions, viz. CSIR-Indian Institute of Chemical Biology, Kolkata, India (IICB/IRB/2020/3P), Medical College Hospital, Kolkata (MC/KOL/IEC/NON-SPON/710/04/2020), India and Infectious Disease & Beleghata General Hospital (ID & BG Hospital), Kolkata, India (IDBGH/Ethics/2429). The RCT was approved by Central Drugs Standard Control Organisation (CDSCO) under Directorate General of Health Services, Ministry of Health & Family Welfare, Govt. of India (approval no. CT/BP/09/2020) and registered with Clinical Trial Registry of India (CTRI, No. CTRI/2020/05/025209), under Indian Council of Medical Research, India.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data used in the manuscript are available with the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 29, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial
Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Abhishake Lahiri, Debaleena Bhowmik, Janani Srinivasa Vasudevan, Ranjeet Maurya, Akshay Kanakan, Sachin Sharma, Manish Kumar, Praveen Singh, Rammohan Roy, Kausik Chaudhury, Rajsekhar Maiti, Saugata Bagchi, Ayan Maiti, Md. Masoom Perwez, Abhinandan Mondal, Avinash Tewari, Samik Mandal, Arpan Roy, Moumita Saha, Durba Biswas, Chikam Maiti, Sayantan Chakraborty, Biswanath Sharma Sarkar, Anima Haldar, Bibhuti Saha, Shantanu Sengupta, Rajesh Pandey, Shilpak Chatterjee, Prasun Bhattacharya, Sandip Paul, Dipyaman Ganguly
medRxiv 2020.11.25.20237883; doi: https://doi.org/10.1101/2020.11.25.20237883
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial
Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Abhishake Lahiri, Debaleena Bhowmik, Janani Srinivasa Vasudevan, Ranjeet Maurya, Akshay Kanakan, Sachin Sharma, Manish Kumar, Praveen Singh, Rammohan Roy, Kausik Chaudhury, Rajsekhar Maiti, Saugata Bagchi, Ayan Maiti, Md. Masoom Perwez, Abhinandan Mondal, Avinash Tewari, Samik Mandal, Arpan Roy, Moumita Saha, Durba Biswas, Chikam Maiti, Sayantan Chakraborty, Biswanath Sharma Sarkar, Anima Haldar, Bibhuti Saha, Shantanu Sengupta, Rajesh Pandey, Shilpak Chatterjee, Prasun Bhattacharya, Sandip Paul, Dipyaman Ganguly
medRxiv 2020.11.25.20237883; doi: https://doi.org/10.1101/2020.11.25.20237883

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (74)
  • Dermatology (49)
  • Emergency Medicine (148)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (176)
  • Epidemiology (4908)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (690)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (325)
  • Health Systems and Quality Improvement (209)
  • Hematology (87)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5414)
  • Intensive Care and Critical Care Medicine (334)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (130)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (203)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (788)
  • Public and Global Health (1833)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (258)
  • Rheumatology (88)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (39)